PMID: 8944917Sep 1, 1996Paper

Bridging to transplant. Equal extended survival for patients undergoing LVAD support when compared with long-term medical management

ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs
S M MehtaW S Pierce

Abstract

Implantation of ventricular assist devices (VADs) to support patients awaiting cardiac transplant has become an effective means of assuring that these critically ill patients survive to transplant. The authors undertook a retrospective analysis of 115 consecutive patients listed for cardiac transplant from January 1992 through June 1995. A VAD was implanted in 19 of these patients. Survival was calculated by intent to treat from the time of transplant listing through heart transplant, if it occurred. The analysis demonstrates that the patients who underwent implantation of a VAD as bridge to transplant had survival times similar to those of patients with medical management. These survival statistics demonstrate the utility of VADs as an effective means to bridge critically ill patients until a suitable donor organ becomes available. In addition, as previous studies have suggested for acute results, earlier implementation and better patient selection may lead to improved long-term survival.

Related Concepts

Related Feeds

Cardiogenic Shock

Cardiogenic shock is a devastating consequence of acute myocardial infarction and is associated with an extremely high mortality. Here is the latest research.

Related Papers

The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
Jill M GelowCraig S Broberg
European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery
Claudia HeilmannKurt Fritzsche
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
David A BaranSteven L Lansman
Journal of Cardiac Surgery
Evgenij V PotapovRoland Hetzer
© 2021 Meta ULC. All rights reserved